MedTrace Logo

Pre-, Peri- and Postnatal Programming and Origins of Disease: Early Targeting the Epidemics of Allergy and Overweight

NCT00167700 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 800

Last updated 2012-10-04

No results posted yet for this study

Summary

Combined programme: Nutrition, Allergy, Mucosal immunology and Intestinal microbiota (NAMI) was created with the objective to reverse the rising trend of chronic inflammatory diseases, such as allergic disease and obesity, by control of the internal and external environments of the infant. To approach this problem, the project aims to characterize

* how immunology is regulated during pregnancy and early infancy,
* how the immune interaction between mother and child is influenced by nutritional and microbial factors, and
* how the regulation is related to disease risk.

Conditions

Interventions

BEHAVIORAL

Dietary counselling and placebo

Counseling to conform with the dietary recommendations. Food products commercially available including spreads and salad dressing. Placebo capsules.

BEHAVIORAL

Dietary counselling and probiotics

Counseling to conform with the dietary recommendations. Food products commercially available including spreads and salad dressing. Probiotics

DIETARY_SUPPLEMENT

Placebo capsules

Placebo capsules

DIETARY_SUPPLEMENT

Probiotics

DIETARY_SUPPLEMENT

Prebiotics

Sponsors & Collaborators

  • Academy of Finland

    collaborator OTHER

  • University of Turku

    lead OTHER

Principal Investigators

  • Erika Isolauri, MD, PhD · University of Turku

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-02-28
Completion
2015-12-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00167700 on ClinicalTrials.gov